These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17264876)

  • 1. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.
    Baelde HJ; Eikmans M; Lappin DW; Doran PP; Hohenadel D; Brinkkoetter PT; van der Woude FJ; Waldherr R; Rabelink TJ; de Heer E; Bruijn JA
    Kidney Int; 2007 Apr; 71(7):637-45. PubMed ID: 17264876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
    Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
    J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
    Lopes TG; de Souza ML; da Silva VD; Dos Santos M; da Silva WIC; Itaquy TP; Garbin HI; Veronese FV
    PLoS One; 2019; 14(6):e0217585. PubMed ID: 31220088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression.
    Turk T; Leeuwis JW; Gray J; Torti SV; Lyons KM; Nguyen TQ; Goldschmeding R
    J Histochem Cytochem; 2009 Jul; 57(7):623-31. PubMed ID: 19255250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells.
    Kondo S; Tanaka N; Kubota S; Mukudai Y; Yosimichi G; Sugahara T; Takigawa M
    Mol Cancer Ther; 2006 Jan; 5(1):129-37. PubMed ID: 16432171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C, -D and associated with shorter survival in gastric cancer.
    Liu L; Li Z; Feng G; You W; Li J
    Pathol Int; 2007 Nov; 57(11):712-8. PubMed ID: 17922682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.
    Abou Msallem J; Chalhoub H; Al-Hariri M; Saad L; Jaffa MA; Ziyadeh FN; Jaffa AA
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F980-90. PubMed ID: 26447218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
    Chen LP; Zhou QL; Peng WS; Wu XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
    Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes.
    Dai HY; Zheng M; Lv LL; Tang RN; Ma KL; Liu D; Wu M; Liu BC
    J Cell Biochem; 2012 Jan; 113(1):293-301. PubMed ID: 21913214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophy and loss of podocytes in diabetic nephropathy.
    Miyauchi M; Toyoda M; Kobayashi K; Abe M; Kobayashi T; Kato M; Yamamoto N; Kimura M; Umezono T; Suzuki D
    Intern Med; 2009; 48(18):1615-20. PubMed ID: 19755763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
    Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
    Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells.
    Liu FY; Xiao L; Peng YM; Duan SB; Liu H; Liu YH; Ling GH; Yuan F; Chen JX; Fu X; Zhu JL
    Chin Med J (Engl); 2007 Feb; 120(3):231-6. PubMed ID: 17355828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
    Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
    Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.